Midgard Science

Labs / Assays & in vitro testing

Bambusa Therapeutics

Boston, MA, United States · bambusatx.com

GMP

Bambusa Therapeutics is a clinical-stage biopharmaceutical company based in Boston, Massachusetts and also operating in Victoria, Australia. It develops bispecific antibodies for immunological and inflammatory disorders, with a pipeline spanning atopic dermatitis, Type 2 inflammatory diseases, inflammatory bowel disease, and autoantibody-driven autoimmune disease.

They take quote requests by email.

What they offer

  • Bispecific antibody discovery and development

    Develops next-generation bispecific antibodies for immunological and inflammatory disorders.

  • Clinical development

    Advances lead antibody candidates through clinical development programs.

  • Preclinical program development

    Advances preclinical candidates for inflammatory bowel disease and autoantibody-driven autoimmune disease.

  • Antibody engineering platform development

    Uses an antibody engineering platform with half-life extension and high-concentration subcutaneous delivery.

What they work on

Modalities
Antibody, Bispecific, ADC, mRNA, Cell therapy
Species and models
E. coli
Therapeutic areas
immunology, inflammation, atopic dermatitis, chronic spontaneous urticaria, prurigo nodularis, asthma, food allergy, chronic rhinosinusitis with nasal polyps, chronic obstructive pulmonary disease, inflammatory bowel disease, autoantibody-driven autoimmune disease, gastroenterology
Sites
Boston, USA · Victoria, Australia
Serves
North America, Australia
Address
22 Boston Wharf Road Floor 7 Boston, MA 02210
Founded
2023

Similar labs. GlycoNex, Inc., Intellective Bio, MYCENAX, ORF Biologics

Found in a contract services directory. Listing built from bambusatx.com. Work here? Claim this listing.

Bambusa Therapeutics · Midgard Science